About: Alan Kaul
Posts by Alan Kaul:
-
October 29, 2012 New England Compounding Center (NECC): Tracking the Sources of Fungal Infections
-
October 19, 2012 New England Compounding Center: A Family Business
-
October 16, 2012 Centers for Medicare and Medicaid (CMS) Targets Hospital Readmissions – Update on Practices and Policy
-
June 12, 2012 Centers for Medicare and Medicaid (CMS) Targets Hospital Readmissions – A Disconnect Among the Hospitals or Poor Education?
Follow Blog via Email
Join 2,107 other subscribers-
Recent Posts
- Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
- FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
Archives
Categories
Meta